Senate Counsel, Research
and Fiscal Analysis
Minnesota Senate Bldg.
95 University Avenue W. Suite 3300
St. Paul, MN 55155
(651) 296-4791
Tom Bottern
Director
   Senate   
State of Minnesota
 
 
 
 
 
S.F. No. 1219 - Expansion of Controlled Substances Schedules
 
Author: Senator Julie A. Rosen
 
Prepared By: Kenneth P. Backhus, Senate Counsel (651/296-4396)
 
Date: March 11, 2015



 

Section 1 amends the law defining Schedule I drugs. Schedule I drugs are drugs that have high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. Adds a number of synthetic drugs to Schedule I.

Section 2 amends the law defining Schedule II drugs. Schedule II drugs have a high potential for abuse, currently accepted medical use in the United States or currently accepted medical use with severe restrictions, and abuse may lead to severe psychological or physical dependence. Adds drugs to the Schedule II list. These drugs  are already listed as federal Schedule II drugs. Thus, these changes conform Minnesota’s Schedule II list to the federal Schedule II list.

Section 3 amends the law defining Schedule III drugs. Schedule III drugs have a potential for abuse less than the substances listed in Schedules I and II, currently accepted medical use in treatment in the United States, and abuse may lead to moderate or low physical dependence or high psychological dependence. Strikes language and adds drugs to the Schedule III list. These changes conform Minnesota’s Schedule III list to the federal Schedule III list.

Section 4 amends the law defining Schedule IV drugs. Schedule IV drugs have a low potential for abuse relative to the substances in Schedule III, currently accepted medical use in treatment in the United States, and abuse may lead to limited physical dependence or psychological dependence relative to the substances in Schedule III. Adds drugs to the Schedule IV list. These drugs are already listed as federal Schedule IV drugs. Thus, these changes conform Minnesota’s Schedule IV list to the federal Schedule IV list.

Section 5 amends the law defining Schedule V drugs. Schedule V drugs have a low potential for abuse relative to the substances listed in Schedule IV, currently accepted medical use in treatment in the United States, and limited physical dependence and/or psychological dependence liability relative to the substances listed in Schedule IV. Adds drugs to the Schedule V list. These drugs are already listed as federal Schedule V drugs. Thus, these changes conform Minnesota’s Schedule V list to the federal Schedule V list.

 

KPB/tg

 
Check on the status of this bill
 
Back to Senate Counsel and Research Bill Summaries page
 

 
This page is maintained by the Office of Senate Counsel, Research, and Fiscal Analysis for the Minnesota Senate.
 
Last review or update: 03/11/2015
 
If you see any errors on this page, please e-mail us at webmaster@senate.mn